saprax 10mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - solifenacin succinate - film coated tablets - 10mg - solifenacin succinate (8000002101) 10mg - solifenacin
saprax 5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - solifenacin succinate - film coated tablets - 5mg - solifenacin succinate (8000002101) 5mg - solifenacin
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - υδροχλωρική κλοπιδογρέλη - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - Αντιθρομβωτικοί παράγοντες - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
mundisal gel 8.71% w/w oral gel
mundipharma pharmaceuticals ltd (0000003104) 13 othellos str, nicosia, 1685, 23661 - choline salicylate - oral gel - 8.71% w/w - choline salicylate (0002016366) 8,7% w/w - other agents for local oral treatment
cotovetol 100/25mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - hydrochlorothiazide; losartan potassium - film coated tablets - 100/25mg - hydrochlorothiazide (0000058935) 25mg; losartan potassium (8000001451) 100mg - losartan and diuretics
cotovetol 50/12.5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - hydrochlorothiazide; losartan potassium - film coated tablets - 50/12.5mg - hydrochlorothiazide (0000058935) 12.5mg; losartan potassium (8000001451) 50mg - losartan and diuretics
seizal 50mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - lamotrigine - tablets - 50mg - lamotrigine (0084057841) 50mg - lamotrigine
seizal 200mg tablet, dispersible
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - lamotrigine - tablet, dispersible - 200mg - lamotrigine (0084057841) 200mg - lamotrigine
seizal 100mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - lamotrigine - tablets - 100mg - lamotrigine (0084057841) 100mg - lamotrigine
seizal 50mg tablet, dispersible
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - lamotrigine - tablet, dispersible - 50mg - lamotrigine (0084057841) 50mg - lamotrigine